InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Adams Helen C.. Director active across 2 companies, notably Prometheus Biosciences, Inc.. Aggregated, 5 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €36k. History available since 19 May 2023. The latest transaction was disclosed on 22 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Adams Helen C. is a director at Immix Biopharma, Inc. and Prometheus Biosciences, Inc. She has 5 filings in total, and across the sampled recent filings from 2023-05-19 to 2026-05-29, the reported buy volume is EUR 35795 and the reported sell volume is EUR 0.